A comprehensive review and update on the pathogenesis of inflammatory bowel disease

Q Guan - Journal of immunology research, 2019 - Wiley Online Library
Inflammatory bowel disease (IBD) is a chronic and life‐threating inflammatory disease of
gastroenteric tissue characterized by episodes of intestinal inflammation. The pathogenesis …

[HTML][HTML] Mechanisms regulating intestinal barrier integrity and its pathological implications

C Chelakkot, J Ghim, SH Ryu - Experimental & molecular medicine, 2018 - nature.com
The gastrointestinal tract is a specialized organ in which dynamic interactions between host
cells and the complex environment occur in addition to food digestion. Together with the …

[HTML][HTML] Prevalence of inflammatory bowel disease among adults aged≥ 18 years—United States, 2015

JM Dahlhamer - MMWR. Morbidity and mortality weekly report, 2016 - cdc.gov
Crohn's disease and ulcerative colitis, collectively known as inflammatory bowel disease,
are characterized by chronic inflammation of the gastrointestinal tract. Inflammatory bowel …

ROS/RNS and base dual activatable merocyanine‐based NIR‐II fluorescent molecular probe for in vivo biosensing

X Zhang, Y Chen, H He, S Wang, Z Lei… - Angewandte …, 2021 - Wiley Online Library
Inflammation usually results in high‐level reactive oxygen species (ROS) and reactive
nitrogen species (RNS) not only in acidic tissue but also in alkaline tissue. However …

[HTML][HTML] The CB2 receptor and its role as a regulator of inflammation

C Turcotte, MR Blanchet, M Laviolette… - Cellular and Molecular …, 2016 - Springer
The CB 2 receptor is the peripheral receptor for cannabinoids. It is mainly expressed in
immune tissues, highlighting the possibility that the endocannabinoid system has an …

[HTML][HTML] Metallothionein 1: A new spotlight on inflammatory diseases

H Dai, L Wang, L Li, Z Huang, L Ye - Frontiers in immunology, 2021 - frontiersin.org
MT1 has been demonstrated to be an essential stress protein in maintaining physiological
balance and regulating immune homeostasis. While the immunological involvement of MT1 …

NLRP3: a promising therapeutic target for autoimmune diseases

HH Shen, YX Yang, X Meng, XY Luo, XM Li… - Autoimmunity …, 2018 - Elsevier
NLRP3, a member of nucleotide-binding domain-(NOD) like receptor family, can be found in
large varieties of immune and non-immune cells. Upon activation, the NLRP3, apoptosis …

An overview of the mechanism of action of the monoclonal antibody vedolizumab

T Wyant, E Fedyk, B Abhyankar - Journal of Crohn's and Colitis, 2016 - academic.oup.com
Vedolizumab is a novel therapeutic monoclonal antibody recently approved for the treatment
of moderately to severely active ulcerative colitis and Crohn's disease in adults who have …

Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing

J Chang, RW Leong, VC Wasinger, M Ip, M Yang… - Gastroenterology, 2017 - Elsevier
Background & Aims Many patients with inflammatory bowel diseases (IBD) have ongoing
bowel symptoms of diarrhea or abdominal pain despite mucosal healing. We investigated …

[HTML][HTML] Microbial pathways in colonic sulfur metabolism and links with health and disease

F Carbonero, AC Benefiel… - Frontiers in …, 2012 - frontiersin.org
Sulfur is both crucial to life and a potential threat to health. While colonic sulfur metabolism
mediated by eukaryotic cells is relatively well studied, much less is known about sulfur …